Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce G Haffty

Showing results (51-60 of 337) with videos related to

Pageof 34
Sort By:
Oncology (Williston Park, N.Y.)|May 4, 2007
Current application and research directions for partial-breast irradiationSharad Goyal, Thomas Kearney, Bruce G Haffty
Cancer Journal (Sudbury, Mass.)|April 25, 2006
Chest wall relapse after mastectomy for ductal carcinoma in situ: a report of 10 cases with a review of the literatureJanet H Kim, Fattaneh Tavassoli, Bruce G Haffty
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2015
Radiation of the Internal Mammary Nodes: Is There a Benefit?Bruce G Haffty, Timothy Whelan, Philip M Poortmans
International Journal of Radiation Oncology, Biology, Physics|October 20, 2006
Regional nodal recurrence in breast cancer patients treated with conservative surgery and radiation therapy (BCS+RT)Sunanda Pejavar, Lynn D Wilson, Bruce G Haffty
The Breast Journal|December 10, 2009
The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histologyMeena S Moran, Qifeng Yang, Bruce G Haffty
Cancer|December 22, 2006
Prognostic significance of vascular endothelial growth factor protein levels in T1-2 N0 laryngeal cancer treated with primary radiation therapyRahul R Parikh, Qifeng Yang, Bruce G Haffty
Medical Physics|July 28, 2007
On the assay of brachytherapy sourcesNing J Yue, Bruce G Haffty, Jinfeng Yue
NPJ Breast Cancer|November 5, 2025
Rewriting the radiation playbook: NSABP B-51 and the rise of pathologic precisionMehran Habibi, Bruce G Haffty, Silvia C Formenti
Cancer|December 13, 2017
The role of postmastectomy radiotherapy in patients with stage II breast cancerNisha Ohri, Bruce G Haffty, Thomas A Buchholz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2008
Should intensity-modulated radiation therapy be the standard of care in the conservatively managed breast cancer patient?Bruce G Haffty, Thomas A Buchholz, Beryl McCormick
Pageof 34

Showing results (51-60 of 337) with videos related to

Sort By:
Pageof 34
Oncology (Williston Park, N.Y.)|May 4, 2007
Current application and research directions for partial-breast irradiationSharad Goyal, Thomas Kearney, Bruce G Haffty
Cancer Journal (Sudbury, Mass.)|April 25, 2006
Chest wall relapse after mastectomy for ductal carcinoma in situ: a report of 10 cases with a review of the literatureJanet H Kim, Fattaneh Tavassoli, Bruce G Haffty
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2015
Radiation of the Internal Mammary Nodes: Is There a Benefit?Bruce G Haffty, Timothy Whelan, Philip M Poortmans
International Journal of Radiation Oncology, Biology, Physics|October 20, 2006
Regional nodal recurrence in breast cancer patients treated with conservative surgery and radiation therapy (BCS+RT)Sunanda Pejavar, Lynn D Wilson, Bruce G Haffty
The Breast Journal|December 10, 2009
The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histologyMeena S Moran, Qifeng Yang, Bruce G Haffty
Cancer|December 22, 2006
Prognostic significance of vascular endothelial growth factor protein levels in T1-2 N0 laryngeal cancer treated with primary radiation therapyRahul R Parikh, Qifeng Yang, Bruce G Haffty
Medical Physics|July 28, 2007
On the assay of brachytherapy sourcesNing J Yue, Bruce G Haffty, Jinfeng Yue
NPJ Breast Cancer|November 5, 2025
Rewriting the radiation playbook: NSABP B-51 and the rise of pathologic precisionMehran Habibi, Bruce G Haffty, Silvia C Formenti
Cancer|December 13, 2017
The role of postmastectomy radiotherapy in patients with stage II breast cancerNisha Ohri, Bruce G Haffty, Thomas A Buchholz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2008
Should intensity-modulated radiation therapy be the standard of care in the conservatively managed breast cancer patient?Bruce G Haffty, Thomas A Buchholz, Beryl McCormick
Pageof 34